Literature DB >> 27504586

The prevalence of hepatitis B infection in central China: An adult population-based serological survey of a large sample size.

Guo Yong Hao1, Feng Da Xing1, Xu Jin1, Feng Xiu Hong1, Dong Pu Mei1, Li Jun1, Ye Ying1, Zhang Yan Yang1, Guo Wan Shen1.   

Abstract

The objective of this study was to determine the prevalence of serum HBsAg among adults in Henan province, China. A provincial serosurvey of people aged 18-74 years was conducted and individuals for analysis were selected using a multistage stratified random cluster sampling method. A 5-ml serum sample from each person was collected and the serum was tested for the presence of HBsAg, HBcAb, HBsAb, HBeAg, and HBeAb by ELISA. Multivariate analysis was used to identify factors associated with the prevalence of HBsAg. A total of 16,685 residents, aged 18-74 years who resided in 60 communities or villages in Henan, China were surveyed. Among the eligible study population, 642 HBsAg positive cases (3.7%) were found. The prevalence increased steadily from 3.1% among population aged 18-35 years old, to 5.1% among population aged 55-74 years. Accordingly, HBsAb declined steadily from 53.4% to 24.7%. Six hundred and forty-two positive HBsAg blood samples were screened for the HBeAg and HBeAb. HBeAg prevalence declined steadily from 27.7% among population age 18-35 years old to 6.8% among population age 55-74 years old. The single factor analysis was used for 16 possible risk factors and multivariate analysis showed that five risk factors were significantly related to HBV infection. HBV infection is a serious public health problem among adult population in Henan. Strengthening administrative regulations of medical practices, especially in rural areas, and providing health education propaganda to the public of HBV infection should be given more attention on public health policy. J. Med. Virol. 89:450-457, 2017.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  HBV prevalence; Henan province China; a large sample size; adult

Mesh:

Substances:

Year:  2016        PMID: 27504586     DOI: 10.1002/jmv.24649

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  8 in total

1.  The effectiveness of 20 μg hepatitis B vaccine used for the prevention of HBV vertical transmission.

Authors:  Guo Yonghao; Chen Yanping; Dou Qiaohua; Feng Daxing; Zhang Yanyang; Zhao Dongyang; Guo Wanshen
Journal:  Sci Rep       Date:  2022-07-11       Impact factor: 4.996

2.  Conventional and genetic risk factors for chronic Hepatitis B virus infection in a community-based study of 0.5 million Chinese adults.

Authors:  Elizabeth Hamilton; Ling Yang; Alexander J Mentzer; Yu Guo; Yiping Chen; Jun Lv; Robert Fletcher; Neil Wright; Kuang Lin; Robin Walters; Christiana Kartsonaki; Yingcai Yang; Sushila Burgess; Sam Sansome; Liming Li; Iona Y Millwood; Zhengming Chen
Journal:  Sci Rep       Date:  2022-07-15       Impact factor: 4.996

3.  Prevalence and influencing factors of hepatitis B among a rural residential population in Zhejiang Province, China: a cross-sectional study.

Authors:  Shigui Yang; Cheng Ding; Yuanxia Cui; Jie Wu; Chengbo Yu; Ping Chen; Kaijin Xu; Min Deng; Yiping Li; Juanjuan Liu; Pei Yin; Wen Ren; Yan Qiu; Qing Cao; Yuqing Zhou; Jun Yao; Bing Ruan; Jingjing Ren; Lanjuan Li
Journal:  BMJ Open       Date:  2017-04-03       Impact factor: 2.692

4.  Seroprevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) among human immunodeficiency virus (HIV)-infected patients in an HBV endemic area in Brazil.

Authors:  Claudinei Mesquita da Silva; Leyde Daiane de Peder; Alessandra Michele Guelere; Josana Dranka Horvath; Eraldo Schunk Silva; Jorge Juarez Vieira Teixeira; Dennis Armando Bertolini
Journal:  PLoS One       Date:  2018-09-07       Impact factor: 3.240

5.  Prevalence and co-infection of schistosomiasis/hepatitis B among rural populations in endemic areas in Hubei, China.

Authors:  Yupeng Zhang; Yaofei Xie; Qi Chen; Xuyu Chen; Zhuangzhuang Dong; Xiaodong Tan
Journal:  Trans R Soc Trop Med Hyg       Date:  2020-02-07       Impact factor: 2.184

6.  12 Months Persistent Immunogenicity after Hepatitis B Vaccination in Patients with Type 2 Diabetes and Immunogenicity of Revaccination in Non-Responders: An Open-Label Randomized Controlled Trial.

Authors:  Bingfeng Han; Wu Liu; Juan Du; Hanyu Liu; Tianshuo Zhao; Shubo Yang; Shuai Wang; Sihui Zhang; Bei Liu; Yaqiong Liu; Fuqiang Cui
Journal:  Vaccines (Basel)       Date:  2021-11-29

7.  Capable Infection of Hepatitis B Virus in Diffuse Large B-cell Lymphoma.

Authors:  Yanchun Wang; Huijie Wang; Shaokun Pan; Tao Hu; Jiabin Shen; Hui Zheng; Suhong Xie; Youhua Xie; Renquan Lu; Lin Guo
Journal:  J Cancer       Date:  2018-04-12       Impact factor: 4.207

8.  Hepatitis B and HIV coinfection in Northern Uganda: Is a decline in HBV prevalence on the horizon?

Authors:  Annacarla Chiesa; Emmanuel Ochola; Letizia Oreni; Paolo Vassalini; Giuliano Rizzardini; Massimo Galli
Journal:  PLoS One       Date:  2020-11-18       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.